Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection (Q41085449)

26 September 2017

title

Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1325010

13 September 2022

main subject

arterial hypertension

1 reference

G. L. Bakris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1325010

13 September 2022

B. W. Barnhill

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1325010

13 September 2022

R. Sadler

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1325010

13 September 2022

language of work or name

English

0 references

publication date

1 April 1992

1 reference

26 September 2017

1 reference

26 September 2017

volume

41

1 reference

26 September 2017

issue

4

1 reference

26 September 2017

page(s)

912-919

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1992.139

26 September 2017

exact match

0 references

cites work

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Angiotensin-converting enzyme inhibitors in the prevention of experimental diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Diabetic nephropathy: hemodynamic basis and implications for disease management

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Salt-sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Angiotensin increases cytosolic free calcium in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Physiology of the mesangial cell

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Mechanism of action of angiotensin II and bradykinin on prostaglandin synthesis and vascular tone in the isolated rat kidney. Effect of Ca++ antagonists and calmodulin inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Calcium antagonists decrease adrenal and vascular responsiveness to angiotensin II in normal man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Reversal of renal cortical actions of angiotensin II by verapamil and manganese

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Inhibition by diltiazem of pressure-induced afferent vasoconstriction in the isolated perfused rat kidney.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

"Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Renal hemodynamic effects of calcium antagonists in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Diltiazem maintains renal vasodilation without hyperfiltration in hypertension: studies in essential hypertension man and the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Effects of different calcium antagonists on proteinuria associated with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Effect of proteinuria on mortality in NIDDM

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

[Calcium antagonists in chronic renal failure. Undesirable effects on glomerular hemodynamics?]

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Hypertension and Renal Selectivity Properties in Diabetic Microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Protective action of calcium channel antagonists in atherogenesis and experimental vascular injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Treatment of hypertension in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1992.139

7 January 2021

Identifiers

DOI

10.1038/KI.1992.139

1 reference

Dimensions Publication ID

26 September 2017

1047693591

0 references

1 reference